Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models

Karin L. Lee, Claudia Palena, John Lee, Kayvan Niazi, Andrew Nguyen, Frank Jones, Shahrooz Rabizadeh, Patrick Soon-Shiong, Jeffrey Schlom, Duane H. Hamilton

Cancer Immunol Res (2020) 8 (4_Supplement): PR20.

https://doi.org/10.1158/2326-6074.TUMIMM18-PR20

Published: 01 April 2020

View article titled, Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models

Journal Articles

Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity

Lucas A. Horn, Jeffrey Riskin, Heidi A. Hempel, Hanne Lind, Kristen Fousek, Duane H. Hamilton, Kristen K. McCampbell, Jeffrey Schlom, Claudia Palena

Cancer Immunol Res (2020) 8 (3_Supplement): B43.

https://doi.org/10.1158/2326-6074.TUMIMM19-B43

Published: 02 March 2020

View article titled, Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity

Journal Articles

Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy

Karin L. Lee, Claudia Palena, Jeffrey Schlom, Duane H. Hamilton

Cancer Immunol Res (2020) 8 (3_Supplement): B29.

https://doi.org/10.1158/2326-6074.TUMIMM19-B29

Published: 02 March 2020

View article titled, Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy

Journal Articles

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Karin L. Lee, Stephen C. Benz, Kristin C. Hicks, Andrew Nguyen, Sofia R. Gameiro, Claudia Palena, John Z. Sanborn, Zhen Su, Peter Ordentlich, Lars Rohlin, John H. Lee, Shahrooz Rabizadeh, Patrick Soon-Shiong, Kayvan Niazi, Jeffrey Schlom, Duane H. Hamilton

Cancer Immunol Res (2019) 7 (8): 1359–1370.

https://doi.org/10.1158/2326-6066.CIR-18-0620

Published: 01 August 2019

View article titled, Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Includes: Supplementary data

Journal Articles

Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models

Karin L. Lee, Andrew T. Nguyen, Steven C. Benz, Shahrooz Rabizadeh, James W. Hodge, Claudia Palena, Jeffrey Schlom, Duane H. Hamilton

Cancer Immunol Res (2018) 6 (9_Supplement): B82.

https://doi.org/10.1158/2326-6074.TUMIMM17-B82

Published: 01 September 2018

View article titled, Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models

Journal Articles

Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells

Duane H. Hamilton, Lesley Mathews-Griner, Jonathan M. Keller, Xin Hu, Noel Southall, Juan Marugan, Justin M. David, Ferrer Ferrer, Jeffrey Schlom, Claudia Palena

Cancer Immunol Res (2017) 5 (3_Supplement): B64.

https://doi.org/10.1158/2326-6074.TUMIMM16-B64

Published: 28 February 2017

View article titled, Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells

Journal Articles

Abstract A42: MK-1775, a WEE1 inhibitor alleviates resistance to immune attack of tumor cells undergoing an epithelial-mesenchymal transition

Duane H. Hamilton, Romaine I. Fernando, Kwong-Yok Tsang, Claudia Palena

Cancer Immunol Res (2015) 3 (10_Supplement): A42.

https://doi.org/10.1158/2326-6074.TUMIMM14-A42

Published: 09 October 2015

View article titled, Abstract A42: MK-1775, a WEE1 inhibitor alleviates resistance to immune attack of tumor cells undergoing an epithelial-mesenchymal transition

NARROW

Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models

Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity

Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models

Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells

Abstract A42: MK-1775, a WEE1 inhibitor alleviates resistance to immune attack of tumor cells undergoing an epithelial-mesenchymal transition

Email alerts

AACR Journals

Abstract PR20: A novel combination immunotherapy with a vaccine targeting tumor neoepitopes that mediates immune cascade in murine tumor models

Abstract B43: Simultaneous inhibition of CXCR1/CXCR2, TGF-β, and PD-L1 overcomes immune resistance driven by tumor plasticity

Abstract B29: The importance of epitope spreading in the generation of effective antitumor immunity in mice treated with combination immunotherapy

Efficient Tumor Clearance and Diversified Immunity through Neoepitope Vaccines and Combinatorial Immunotherapy

Abstract B82: Identification of tumor neoantigens for combination therapy in murine tumor models

Abstract B64: A high-throughput screen identifies fulvestrant as an enhancer of immune-mediated cytotoxicity of mesenchymal-like lung cancer cells

Abstract A42: MK-1775, a WEE1 inhibitor alleviates resistance to immune attack of tumor cells undergoing an epithelial-mesenchymal transition

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only